+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Sorafenib Global Market Insights 2023, Analysis and Forecast to 2028, by Market Participants, Regions, Technology, Application, Product Type

  • PDF Icon

    Report

  • 107 Pages
  • October 2023
  • Region: Global
  • Prof Research
  • ID: 4474969
Description Jump to:

Quick Summary:

In the constantly evolving pharmaceutical industry, being armed with the most accurate, in-depth, and up-to-date information about the global market of Sorafenib is paramount. A critical chemotherapy drug administered for kidney, liver and thyroid cancer treatment, Sorafenib continues to define longevity and quality of life for patients worldwide and holds massive potential for future growth and advancements. Our meticulously designed market research report provides an extensive coverage of the global Sorafenib market, breaking down complex market dynamics into comprehensible insights.

This comprehensive report dives into exhaustive regional analysis covering North America, South America, Asia & Pacific, Europe, and Middle East & Africa, highlighting market forces and trends. The analysis extends to the competitor landscape, spotlighting key global players alongside smaller contenders. Detailed company profiles, business information, SWOT analysis, and revenue, gross margin and market share information for each player are presented. Furthermore, a categorical focus on various types of drugs within Sorafenib – patented and generic, and their applications, reinforces the report’s holistic approach.

This report describes the global market size of Sorafenib from 2018 to 2022 and its CAGR from 2018 to 2022, and also forecasts its market size to the end of 2028 and its CAGR from 2023 to 2028.

For the geography segment, regional supply, demand, major players, price is presented from 2018 to 2028.

This report covers the following regions:

  • North America
  • South America
  • Asia & Pacific
  • Europe
  • MEA
The key countries for each region are also included such as the United States, China, Japan, India, Korea, ASEAN, Germany, France, UK, Italy, Spain, CIS, and Brazil etc.

For the competitor segment, the report includes global key players of Sorafenib as well as some small players.

The information for each competitor includes:

  • Company Profile
  • Business Information
  • SWOT Analysis
  • Revenue, Gross Margin and Market Share

Applications Segment:

  • Kidney Cancer
  • Liver Cancer
  • Thyroid Cancer
  • Other

Types Segment:

  • Patented Drugs
  • Generic Drugs

Companies Covered:

  • Pfizer
  • Allergan
  • Alnylam Pharmaceuticals
  • Acceleron Pharma
  • Biocon
  • Bionomics
  • CASI Pharmaceuticals
  • Celgene Corporation
  • Enzon Pharmaceuticals
  • Five Prime Therapeutics
Base Year: 2023
Historical Data: from 2018 to 2022
Forecast Data: from 2023 to 2028


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1 Executive SummaryChapter 2 Abbreviation and Acronyms
Chapter 3 Preface
3.1 Research Scope
3.2 Research Sources
3.2.1 Data Sources
3.2.2 Assumptions
3.3 Research Method
Chapter Four Market Landscape
4.1 Market Overview
4.2 Classification/Types
4.3 Application/End Users
Chapter 5 Market Trend Analysis
5.1 Introduction
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Threats
5.6 Covid-19 Impact
Chapter 6 Industry Chain Analysis
6.1 Upstream/Suppliers Analysis
6.2 Sorafenib Analysis
6.2.1 Technology Analysis
6.2.2 Cost Analysis
6.2.3 Market Channel Analysis
6.3 Downstream Buyers/End Users
Chapter 7 Latest Market Dynamics
7.1 Latest News
7.2 Merger and Acquisition
7.3 Planned/Future Project
7.4 Policy Dynamics
Chapter 8 Historical and Forecast Sorafenib Market in North America (2018-2028)
8.1 Sorafenib Market Size
8.2 Sorafenib Market by End Use
8.3 Competition by Players/Suppliers
8.4 Sorafenib Market Size by Type
8.5 Key Countries Analysis
8.5.1 United States
8.5.2 Canada
8.5.3 Mexico
Chapter 9 Historical and Forecast Sorafenib Market in South America (2018-2028)
9.1 Sorafenib Market Size
9.2 Sorafenib Market by End Use
9.3 Competition by Players/Suppliers
9.4 Sorafenib Market Size by Type
9.5 Key Countries Analysis
9.5.1 Brazil
9.5.2 Argentina
9.5.3 Chile
9.5.4 Peru
Chapter 10 Historical and Forecast Sorafenib Market in Asia & Pacific (2018-2028)
10.1 Sorafenib Market Size
10.2 Sorafenib Market by End Use
10.3 Competition by Players/Suppliers
10.4 Sorafenib Market Size by Type
10.5 Key Countries Analysis
10.5.1 China
10.5.2 India
10.5.3 Japan
10.5.4 South Korea
10.5.5 Southeast Asia
10.5.6 Australia
Chapter 11 Historical and Forecast Sorafenib Market in Europe (2018-2028)
11.1 Sorafenib Market Size
11.2 Sorafenib Market by End Use
11.3 Competition by Players/Suppliers
11.4 Sorafenib Market Size by Type
11.5 Key Countries Analysis
11.5.1 Germany
11.5.2 France
11.5.3 United Kingdom
11.5.4 Italy
11.5.5 Spain
11.5.6 Belgium
11.5.7 Netherlands
11.5.8 Austria
11.5.9 Poland
11.5.10 Russia
Chapter 12 Historical and Forecast Sorafenib Market in MEA (2018-2028)
12.1 Sorafenib Market Size
12.2 Sorafenib Market by End Use
12.3 Competition by Players/Suppliers
12.4 Sorafenib Market Size by Type
12.5 Key Countries Analysis
12.5.1 Egypt
12.5.2 Israel
12.5.3 South Africa
12.5.4 Gulf Cooperation Council Countries
12.5.5 Turkey
Chapter 13 Summary For Global Sorafenib Market (2018-2023)
13.1 Sorafenib Market Size
13.2 Sorafenib Market by End Use
13.3 Competition by Players/Suppliers
13.4 Sorafenib Market Size by Type
Chapter 14 Global Sorafenib Market Forecast (2023-2028)
14.1 Sorafenib Market Size Forecast
14.2 Sorafenib Application Forecast
14.3 Competition by Players/Suppliers
14.4 Sorafenib Type Forecast
Chapter 15 Analysis of Global Key Vendors
15.1 Pfizer
15.1.1 Company Profile
15.1.2 Main Business and Sorafenib Information
15.1.3 SWOT Analysis of Pfizer
15.1.4 Pfizer Sorafenib Revenue, Gross Margin and Market Share (2018-2023)
15.2 Allergan
15.2.1 Company Profile
15.2.2 Main Business and Sorafenib Information
15.2.3 SWOT Analysis of Allergan
15.2.4 Allergan Sorafenib Revenue, Gross Margin and Market Share (2018-2023)
15.3 Alnylam Pharmaceuticals
15.3.1 Company Profile
15.3.2 Main Business and Sorafenib Information
15.3.3 SWOT Analysis of Alnylam Pharmaceuticals
15.3.4 Alnylam Pharmaceuticals Sorafenib Revenue, Gross Margin and Market Share (2018-2023)
15.4 Acceleron Pharma
15.4.1 Company Profile
15.4.2 Main Business and Sorafenib Information
15.4.3 SWOT Analysis of Acceleron Pharma
15.4.4 Acceleron Pharma Sorafenib Revenue, Gross Margin and Market Share (2018-2023)
15.5 Biocon
15.5.1 Company Profile
15.5.2 Main Business and Sorafenib Information
15.5.3 SWOT Analysis of Biocon
15.5.4 Biocon Sorafenib Revenue, Gross Margin and Market Share (2018-2023)
15.6 Bionomics
15.6.1 Company Profile
15.6.2 Main Business and Sorafenib Information
15.6.3 SWOT Analysis of Bionomics
15.6.4 Bionomics Sorafenib Revenue, Gross Margin and Market Share (2018-2023)
15.7 CASI Pharmaceuticals
15.7.1 Company Profile
15.7.2 Main Business and Sorafenib Information
15.7.3 SWOT Analysis of CASI Pharmaceuticals
15.7.4 CASI Pharmaceuticals Sorafenib Revenue, Gross Margin and Market Share (2018-2023)
15.8 Celgene Corporation
15.8.1 Company Profile
15.8.2 Main Business and Sorafenib Information
15.8.3 SWOT Analysis of Celgene Corporation
15.8.4 Celgene Corporation Sorafenib Revenue, Gross Margin and Market Share (2018-2023)
15.9 Enzon Pharmaceuticals
15.9.1 Company Profile
15.9.2 Main Business and Sorafenib Information
15.9.3 SWOT Analysis of Enzon Pharmaceuticals
15.9.4 Enzon Pharmaceuticals Sorafenib Revenue, Gross Margin and Market Share (2018-2023)
15.10 Five Prime Therapeutics
15.10.1 Company Profile
15.10.2 Main Business and Sorafenib Information
15.10.3 SWOT Analysis of Five Prime Therapeutics
15.10.4 Five Prime Therapeutics Sorafenib Revenue, Gross Margin and Market Share (2018-2023)
Tables and Figures
Table Abbreviation and Acronyms
Table Research Scope of Sorafenib Report
Table Data Sources of Sorafenib Report
Table Major Assumptions of Sorafenib Report
Figure Market Size Estimated Method
Figure Major Forecasting Factors
Figure Sorafenib Picture
Table Sorafenib Classification
Table Sorafenib Applications
Table Drivers of Sorafenib Market
Table Restraints of Sorafenib Market
Table Opportunities of Sorafenib Market
Table Threats of Sorafenib Market
Table Covid-19 Impact For Sorafenib Market
Table Raw Materials Suppliers
Table Different Production Methods of Sorafenib
Table Cost Structure Analysis of Sorafenib
Table Key End Users
Table Latest News of Sorafenib Market
Table Merger and Acquisition
Table Planned/Future Project of Sorafenib Market
Table Policy of Sorafenib Market
Table 2018-2028 North America Sorafenib Market Size
Figure 2018-2028 North America Sorafenib Market Size and CAGR
Table 2018-2028 North America Sorafenib Market Size by Application
Table 2018-2023 North America Sorafenib Key Players Revenue
Table 2018-2023 North America Sorafenib Key Players Market Share
Table 2018-2028 North America Sorafenib Market Size by Type
Table 2018-2028 United States Sorafenib Market Size
Table 2018-2028 Canada Sorafenib Market Size
Table 2018-2028 Mexico Sorafenib Market Size
Table 2018-2028 South America Sorafenib Market Size
Figure 2018-2028 South America Sorafenib Market Size and CAGR
Table 2018-2028 South America Sorafenib Market Size by Application
Table 2018-2023 South America Sorafenib Key Players Revenue
Table 2018-2023 South America Sorafenib Key Players Market Share
Table 2018-2028 South America Sorafenib Market Size by Type
Table 2018-2028 Brazil Sorafenib Market Size
Table 2018-2028 Argentina Sorafenib Market Size
Table 2018-2028 Chile Sorafenib Market Size
Table 2018-2028 Peru Sorafenib Market Size
Table 2018-2028 Asia & Pacific Sorafenib Market Size
Figure 2018-2028 Asia & Pacific Sorafenib Market Size and CAGR
Table 2018-2028 Asia & Pacific Sorafenib Market Size by Application
Table 2018-2023 Asia & Pacific Sorafenib Key Players Revenue
Table 2018-2023 Asia & Pacific Sorafenib Key Players Market Share
Table 2018-2028 Asia & Pacific Sorafenib Market Size by Type
Table 2018-2028 China Sorafenib Market Size
Table 2018-2028 India Sorafenib Market Size
Table 2018-2028 Japan Sorafenib Market Size
Table 2018-2028 South Korea Sorafenib Market Size
Table 2018-2028 Southeast Asia Sorafenib Market Size
Table 2018-2028 Australia Sorafenib Market Size
Table 2018-2028 Europe Sorafenib Market Size
Figure 2018-2028 Europe Sorafenib Market Size and CAGR
Table 2018-2028 Europe Sorafenib Market Size by Application
Table 2018-2023 Europe Sorafenib Key Players Revenue
Table 2018-2023 Europe Sorafenib Key Players Market Share
Table 2018-2028 Europe Sorafenib Market Size by Type
Table 2018-2028 Germany Sorafenib Market Size
Table 2018-2028 France Sorafenib Market Size
Table 2018-2028 United Kingdom Sorafenib Market Size
Table 2018-2028 Italy Sorafenib Market Size
Table 2018-2028 Spain Sorafenib Market Size
Table 2018-2028 Belgium Sorafenib Market Size
Table 2018-2028 Netherlands Sorafenib Market Size
Table 2018-2028 Austria Sorafenib Market Size
Table 2018-2028 Poland Sorafenib Market Size
Table 2018-2028 Russia Sorafenib Market Size
Table 2018-2028 MEA Sorafenib Market Size
Figure 2018-2028 MEA Sorafenib Market Size and CAGR
Table 2018-2028 MEA Sorafenib Market Size by Application
Table 2018-2023 MEA Sorafenib Key Players Revenue
Table 2018-2023 MEA Sorafenib Key Players Market Share
Table 2018-2028 MEA Sorafenib Market Size by Type
Table 2018-2028 Egypt Sorafenib Market Size
Table 2018-2028 Israel Sorafenib Market Size
Table 2018-2028 South Africa Sorafenib Market Size
Table 2018-2028 Gulf Cooperation Council Countries Sorafenib Market Size
Table 2018-2028 Turkey Sorafenib Market Size
Table 2018-2023 Global Sorafenib Market Size by Region
Table 2018-2023 Global Sorafenib Market Size Share by Region
Table 2018-2023 Global Sorafenib Market Size by Application
Table 2018-2023 Global Sorafenib Market Share by Application
Table 2018-2023 Global Sorafenib Key Vendors Revenue
Figure 2018-2023 Global Sorafenib Market Size and Growth Rate
Table 2018-2023 Global Sorafenib Key Vendors Market Share
Table 2018-2023 Global Sorafenib Market Size by Type
Table 2018-2023 Global Sorafenib Market Share by Type
Table 2023-2028 Global Sorafenib Market Size by Region
Table 2023-2028 Global Sorafenib Market Size Share by Region
Table 2023-2028 Global Sorafenib Market Size by Application
Table 2023-2028 Global Sorafenib Market Share by Application
Table 2023-2028 Global Sorafenib Key Vendors Revenue
Figure 2023-2028 Global Sorafenib Market Size and Growth Rate
Table 2023-2028 Global Sorafenib Key Vendors Market Share
Table 2023-2028 Global Sorafenib Market Size by Type
Table 2023-2028 Sorafenib Global Market Share by Type

Companies Mentioned

  • Pfizer
  • Allergan
  • Alnylam Pharmaceuticals
  • Acceleron Pharma
  • Biocon
  • Bionomics
  • CASI Pharmaceuticals
  • Celgene Corporation
  • Enzon Pharmaceuticals
  • Five Prime Therapeutics

Methodology

Loading
LOADING...

Related Topics

Related Reports

Sorafenib (CAS 284461-73-0) Global Market Research Report 2024 - Product Image

Sorafenib (CAS 284461-73-0) Global Market Research Report 2024

  • Report
  • 50 Pages
  • Global
From
Thyroid Cancer Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F - Product Image

Thyroid Cancer Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F

  • Report
  • 188 Pages
  • Global
From
Japan Kidney Cancer Drugs Market, By Region, Competition, Forecast and Opportunities, 2020-2030F - Product Image

Japan Kidney Cancer Drugs Market, By Region, Competition, Forecast and Opportunities, 2020-2030F

  • Report
  • 80 Pages
  • Japan
From
Kidney Cancer Drugs Global Market Report 2024 - Product Image

Kidney Cancer Drugs Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Advanced Merkel cell carcinoma - Pipeline Insight, 2024 - Product Image

Advanced Merkel cell carcinoma - Pipeline Insight, 2024

  • Drug Pipelines
  • 80 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.